Chinese Firm Cited for Recordkeeping Violations, Inadequate Testing

The FDA hit Tianjin-Jingye Fine Chemicals with a Form 483 for 14 violations, ranging from inappropriate re-injection and outdated stability research to lack of hand-washing facilities.
Source: Drug Industry Daily